WT1 and acute myeloid leukemia: Based on the classical molecular landscape of 1540 AML patients, 4% (60/1540) of patients were classified with typical t(15;17)(q22;q12), and the most common mutants were FLT3-ITD and WT1 that account for 35% and 17%, respectively, in APL cases [2].